Special article
2024 Spanish Society of Internal Medicine (SEMI) recommendations for the management of cancer-associated venous thrombosis
Recomendaciones 2024 de la Sociedad Española de Medicina Interna (SEMI) para el manejo de la trombosis venosa asociada al cáncer
Aurora Villalobosa, Reina Valleb, Javier Pagán-Escribanoc,d, María Ortize, Pablo Demelo-Rodríguezf,g,h, Carme Fonti,
Corresponding author
a Servicio de Medicina Interna, Hospital Universitario Regional de Málaga
b Servicio de Medicina Interna, Hospital Sierrallana, Torrelavega
c Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario José María Morales Meseguer
d Centro Regional de Hemodonación, Servicio Murciano de Salud
e Servicio de Medicina Interna, Hospital Clinic de Barcelona
f Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón
g Instituto de Investigación Sanitaria Gregorio Marañón
h Facultad de Medicina, Universidad Complutense de Madrid
i Servicio de Oncología Médica, Hospital Clinic de Barcelona
Ver másRead
Not available
Timeswas read the article
Total PDF
Total HTML
Share statistics
array:22 [ "pii" => "S2254887424001371" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.10.007" "estado" => "S5" "fechaPublicacion" => "2024-10-29" "aid" => "2245" "copyright" => "Elsevier Ltd. All rights reserved" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:16 [ "pii" => "S2254887424001413" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.10.011" "estado" => "S5" "fechaPublicacion" => "2024-10-31" "aid" => "2249" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Circadian pattern of blood pressure in patients with stable COPD" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Patrón circadiano de presión arterial en pacientes con EPOC estable" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Díez-Manglano, J.A. Díaz-Peromingo, R. Boixeda-Viu" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Díez-Manglano" ] 1 => array:2 [ "nombre" => "J.A." "apellidos" => "Díaz-Peromingo" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Boixeda-Viu" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001413?idApp=WRCEE" "url" => "/22548874/unassign/S2254887424001413/v1_202410310625/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S2254887424001103" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.08.001" "estado" => "S200" "fechaPublicacion" => "2024-08-28" "aid" => "2233" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El receptor soluble para productos finales de glicación avanzada se correlacionó positivamente con la lesión renal con la enfermedad coronaria" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1825 "Ancho" => 3341 "Tamanyo" => 319191 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Correlation analysis between sRAGE and uACR in CHD patients (A), and ROC analysis of sRAGE, UMA, eGFR, SCr, UCr, Albumin and BUN with uACR ≥ 30 mg/g in CHD patients (B).</p> <p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Each dot represents an individual patient. BUN: blood urea nitrogen; CHD: coronary heart disease; eGFR: estimated Glomerular Filtration Rate; ROC: receiver operating characteristic; SCr: serum creatinine; sRAGE: soluble receptor for advanced glycation end products; uACR: urinary albumin to creatinine ratio; UCr: urine creatinine; UMA: urine microalbumin.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Lu Chen, Xiang-Jun Zeng, Xin-Ying Guo, Jian Liu, Feng-He Du, Cai-Xia Guo" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Lu" "apellidos" => "Chen" ] 1 => array:2 [ "nombre" => "Xiang-Jun" "apellidos" => "Zeng" ] 2 => array:2 [ "nombre" => "Xin-Ying" "apellidos" => "Guo" ] 3 => array:2 [ "nombre" => "Jian" "apellidos" => "Liu" ] 4 => array:2 [ "nombre" => "Feng-He" "apellidos" => "Du" ] 5 => array:2 [ "nombre" => "Cai-Xia" "apellidos" => "Guo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256524001498" "doi" => "10.1016/j.rce.2024.06.016" "estado" => "S200" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256524001498?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001103?idApp=WRCEE" "url" => "/22548874/unassign/S2254887424001103/v1_202408280421/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "2024 Spanish Society of Internal Medicine (SEMI) recommendations for the management of cancer-associated venous thrombosis" "tieneTextoCompleto" => 0 "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Aurora Villalobos, Reina Valle, Javier Pagán-Escribano, María Ortiz, Pablo Demelo-Rodríguez, Carme Font" "autores" => array:6 [ 0 => array:3 [ "nombre" => "Aurora" "apellidos" => "Villalobos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Reina" "apellidos" => "Valle" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Javier" "apellidos" => "Pagán-Escribano" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "María" "apellidos" => "Ortiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "Pablo" "apellidos" => "Demelo-Rodríguez" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 5 => array:4 [ "nombre" => "Carme" "apellidos" => "Font" "email" => array:2 [ 0 => "Carme.fontpuig@gmail.com" 1 => "CFONT@clinic.cat" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:9 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Universitario Regional de Málaga" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Sierrallana, Torrelavega" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario José María Morales Meseguer" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Centro Regional de Hemodonación, Servicio Murciano de Salud" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Clinic de Barcelona" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Instituto de Investigación Sanitaria Gregorio Marañón" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Facultad de Medicina, Universidad Complutense de Madrid" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servicio de Oncología Médica, Hospital Clinic de Barcelona" "etiqueta" => "i" "identificador" => "aff0045" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Recomendaciones 2024 de la Sociedad Española de Medicina Interna (SEMI) para el manejo de la trombosis venosa asociada al cáncer" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2024-04-24" "fechaAceptado" => "2024-09-02" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1899800" "palabras" => array:3 [ 0 => "cancer-associated thrombosis" 1 => "paraneoplastic thrombosis" 2 => "consensus recommendations for clinical practice" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1899799" "palabras" => array:3 [ 0 => "Trombosis asociada al cáncer" 1 => "Trombosis paraneoplásica" 2 => "Recomendaciones de consenso para la práctica clínica" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Venous thromboembolic disease (VTD) is a common complication associated to greater mortality in patients with cancer. Its etiology is multifactorial and depends on the characteristics and co-morbidities of the patient, the tumor type and extension, and the oncological treatment. The management of VTD is more complex in patients with cancer due to an increased risk of recurrence and major bleeding complications during anticoagulation compared to the general non-oncological population. The above differences have led to the development of specific clinical trials to assess the efficacy and safety of anticoagulant therapy in patients with cancer. The present clinical guidelines are intended to provide general recommendations on the management of cancer-associated VTD according to updated according to the most recent scientific evidence.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">La enfermedad tromboembólica venosa (ETV) es una complicación frecuente y que se asocia a mayor mortalidad en los pacientes con cáncer. Su etiología es multifactorial y depende de las características y comorbilidades del paciente, del tipo y extensión del tumor y del tratamiento oncológico. El manejo de la ETV en los pacientes con cáncer es más complejo debido a un mayor riesgo de recurrencia a pesar del tratamiento anticoagulante y de complicaciones hemorrágicas comparado con la población general. Estas diferencias han llevado al desarrollo de ensayos clínicos específicos para evaluar la eficacia y seguridad del tratamiento anticoagulante en la población oncológica. Estas guías pretenden dar recomendaciones generales sobre el manejo de la ETV asociada al cáncer según la evidencia científica más reciente.</p></span>" ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/unassign/S2254887424001371/v1_202410291020/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/22548874/unassign/S2254887424001371/v1_202410291020/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424001371?idApp=WRCEE" ]
